PJAK2 (1001–1013) - CAS 1259928-08-9

PJAK2 (1001–1013) acts as a SOCS1/3 antagonist, enhancing the JAK/STAT signaling pathway by inhibiting the negative regulatory effects of SOCS proteins, thereby playing a crucial role in antiviral immune responses.

JAK

Tyrosine Kinase/Adaptors, JAK/STAT signaling, Stem Cells, Angiogenesis, Chromatin/Epigenetic

1259928-08-9

C76H118N17O26P

1716.82

C([C@H](CC(C)C)N)(=O)N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC2=CC=C(OP(=O)(O)O)C=C2)C(N[C@@H](CC3=CC=C(O)C=C3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N4[C@H](C(O)=O)CCC4)CCC(O)=O)=O)CCCCN)=O)C(C)C)=O)CCCCN)=O)=O)=O)CCC(O)=O)=O)CCCCN)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC1

-20°C

Ice Packs

Peptide